The vicious vortex doesn’t wait. Neither should you. Prescribe now.

SmartVest®
Break The Cycle:

Clear Airways FirstTM

Bronchiectasis can be unrelenting. Once the vicious vortex begins, it only accelerates. New drugs may help reduce inflammation but they don’t clear mucus. And without airway clearance, inflammation and infection can continue to spiral.

The SmartVest® Airway Clearance System is a clinically proven solution designed to disrupt the vicious vortex at its source.

By clearing the airways first, SmartVest® improves quality of life1 and helps preserve lung health2,  making it the essential first step in any multimodal treatment plan.

Most patients meet the criteria. Most still don’t get the therapy.

According to a recent analysis of the U.S. Bronchiectasis and NTM Research Registry (BRR):3

58%

Of qualifying patients did not receive high frequency chest wall oscillation (HFCWO) therapy.3

Qualifying patients not prescribed HFCWO had a higher incidence of asthma, COPD, shortness of breath, and cough.3

During the three-year follow-up, 13% of patients not prescribed HFCWO at baseline later received it—and were found to be more clinically unstable, with higher rates of exacerbations, hospitalizations, and antibiotic use3

Evidence shows introduction of SmartVest® HFCWO improves patient outcomes.1

SmartVest® helps stabilize lung function, reduce the need for antibiotics and emergency care, and improve patients’ quality of life.1

  • 57%
    reduction in antibiotic use1
  • 60%
    reduction in emergency visits1
  • 59%
    reduction in hospitalizations1
  • 68%
    reported improved quality of life1
Read the Study

Don’t wait for multiple exacerbations. Protect lung health from the start.

Letting mucus persist puts patients at risk. An early SmartVest® prescription can help. When your bronchiectasis patient presents with a chronic productive cough, frequent respiratory infections, or visible mucus on imaging, it’s time to intervene.

With a bronchiectasis diagnosis, chronic productive cough lasting 6+ months, and tried-and-failed documentation, SmartVest® can be prescribed immediately.

Start Prescribing SmartVest®

Why targeting inflammation isn’t enough.

New medication offers a promising approach to reduce inflammation but it doesn’t address the mucus buildup that drives the vicious vortex of infection, inflammation, and irreversible lung damage.7

SmartVest® works where medication alone cannot—clearing mucus that traps bacteria and worsens symptoms. By removing this fuel source, SmartVest helps reduce the risk of exacerbations and gives your patients a more complete path to long-term stability.2

Brinsupri™ 6,7SmartVest® 2
Reduces Inflammation✔️❌
Clears Mucus❌✔️
Improves Sputum Expulsion❌✔️
Reduces Infection Risk✔️✔️

SmartVest® patients report real relief and the real-world data reflects it.

Studies and patient data show consistent benefits in both outcome measures and satisfaction:

  • 97%

    report feeling better after using SmartVest*

  • 99%

    report improved ability to expel sputum*

  • 81%

    report less rescue inhaler use*

  • 94%

    would recommend SmartVest*

Don’t settle for an incomplete solution.

Stop the vortex. Treat smart from the start.

Start Prescribing SmartVest® Today
Complete Bronchiectasis Care
References
  1. Sievert C et al. Respiratory Therapy. 2016;11(4):34-38.
  2. Powner J, et al. BMC Pulm Med. 2019;19(1):82.
  3. Feir C et al. WBC Poster 2025.
  4. Dekoven M et al. Am J Respir Crit Care Med. 2022;205:A3090.
  5. DeKoven M et al. IQVIA PharMetrics Plus for MedTech; 2018–2019.
  6. BRINSUPRI [package insert]. Bridgewater, NJ: Insmed Incorporated; 2025.
  7. ASPEN Study, ClinicalTrials.gov Identifier: NCT04594369.

©SmartVest is a registered trademark of Electromed, Inc.
©Brinsupri is a trademark of Insmed Incorporated.

SmartVest Airway Clearance System
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. View Electromed's Notice of Privacy here.

In addition to Electromed’s Notice of Privacy, CA residents have the following rights under CCPA

  • The right to opt out of having their data sold to third parties. Electromed does not sell any information we may collect.
  • The right to request their data be deleted.
  • The right to equal services and price. (i.e. cannot be discriminated against based on their choice to exercise their rights).

If you are a California resident and you want to submit a request or inquiry to us regarding your California rights, you or your authorized agent can contact us at info@electromed.com or write a letter to Electromed, Inc. 500 Sixth Ave NW, New Prague MN 56071. Please indicate in the subject line that you are a California resident making a “California Shine the Light” inquiry.